tiprankstipranks
Insulet sees FY24 revenue growth 20%-21%
PremiumThe FlyInsulet sees FY24 revenue growth 20%-21%
14d ago
Insulet sees Q4 revenue growth 12%-15%
Premium
The Fly
Insulet sees Q4 revenue growth 12%-15%
14d ago
Insulet sees FY24 gross margin approximately 69%
Premium
The Fly
Insulet sees FY24 gross margin approximately 69%
14d ago
Apple tested blood-sugar app, does not plan to release, Bloomberg says
PremiumThe FlyApple tested blood-sugar app, does not plan to release, Bloomberg says
27d ago
Insulet price target raised to $260 from $213 at Raymond James
Premium
The Fly
Insulet price target raised to $260 from $213 at Raymond James
1M ago
Insulet price target raised to $260 from $250 at BTIG
Premium
The Fly
Insulet price target raised to $260 from $250 at BTIG
1M ago
Insulet FDA approval comes early with broad label, says TD Cowen
PremiumThe FlyInsulet FDA approval comes early with broad label, says TD Cowen
3M ago
Early notable gainers among liquid option names on August 27th
Premium
The Fly
Early notable gainers among liquid option names on August 27th
3M ago
Insulet: Omnipod 5 now FDA-cleared for people with Type 2 diabetes
Premium
The Fly
Insulet: Omnipod 5 now FDA-cleared for people with Type 2 diabetes
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100